Chime Financial, Inc.
NASDAQCHYM upgraded to Buy by Rothschild & Co with $46 price target, up from Neutral; stock at $33, target implies 39% upside.
Snapshot as of 7 Oct 2026
CHYM enters September in a peculiar position — up nearly 38% in a month but surrendering 4.4% in a single session, with insiders cashing out and analysts scrambling to catch up on price targets they only just…
CHYM reports its first earnings as a public company tonight, entering the print with a short position that has built sharply since listing — a tension set against a stock that has rallied 24% over the past month. The…
CHYM heads into the week with an unusual split: shorts have quietly added exposure over the past month, yet the Street just opened with a fresh bullish initiation from a major bank. Barclays kicked off coverage this…
CHYM reported Q1 earnings after the close on May 6 that cleared every bar — EPS of $0.13 against a $0.03 estimate, revenue of $647M beating the $636M consensus — and then raised full-year sales guidance to…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CHYM — free to start on ORTEX.
Sign up for free →Open CHYM on ORTEX